Capricor Therapeutics Inc (CAPR)

[mick]

OUTSTANDING INTERVIEW !!!!! $CAPR

REE;
$CAPR New Covid-19 Trial Must be Good!:

@ABC7 recently interviewed 1 of our patients who was treated for COVID19 using our lead asset, CAP1002. This treatment - used for DMD patients – has shown promising preliminary data in COVID19 patients. Watch the full story here: https://t.co/x7EID43Vrj #CAP1002 #COVID19 $CAPR pic.twitter.com/c5m6JYkhCF

— Capricor Therapeutics (@Capricor) May 20, 2020